Low doses of ozone alleviate cardiomyocyte ferroptosis induced by hypoxia-reoxygenation injury via the AMPK-mTOR pathway. (PubMed, Eur J Med Res) - Jul 3, 2025 - "Low-concentration ozone treatment has shown promise in mitigating ferroptosis by regulating the AMPK-mTOR pathway, highlighting its potential as a therapeutic agent for hypoxia-reoxygenation injury."
Journal • Cardiovascular • Congestive Heart Failure • Heart Failure • Myocardial Infarction • Reperfusion Injury
|